Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 12
Submit an article Journal homepage
654
Views
2
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Pirfenidone 5-hydroxylation is mainly catalysed by CYP1A2 and partly catalysed by CYP2C19 and CYP2D6 in the human liver

Yongjie Zhanga Clinical Pharmacokinetics Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China;b WPI Nano Life Science Institute, Kanazawa University, Kanazawa, Japan
,
Rei Satoc Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan
,
Tatsuki Fukamib WPI Nano Life Science Institute, Kanazawa University, Kanazawa, Japan;c Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan
,
Masataka Nakanob WPI Nano Life Science Institute, Kanazawa University, Kanazawa, Japan;c Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan
&
Miki Nakajimab WPI Nano Life Science Institute, Kanazawa University, Kanazawa, Japan;c Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, JapanCorrespondence[email protected]
Pages 1352-1359 | Received 06 Sep 2021, Accepted 14 Nov 2021, Published online: 30 Nov 2021

References

  • Achour B, Barber J, Rostami-Hodjegan A. 2014. Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis. Drug Metab Dispos. 42(8):1349–1356.
  • Amano T, Fukami T, Ogiso T, Hirose D, Jones JP, Taniguchi T, Nakajima M. 2018. Identification of enzymes responsible for dantrolene metabolism in the human liver: a clue to uncover the cause of liver injury. Biochem Pharmacol. 151:69–78.
  • Cottin V, Koschel D, Günther A, Albera C, Azuma A, Sköld CM, Tomassetti S, Hormel P, Stauffer JL, Strombom I, et al. 2018. Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry. ERJ Open Res. 4(4):00084–2018.
  • Crespi CL. 1995. Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research. Adv Drug Res. 26:179–235.
  • European Medicines Agency. 2017. Esbriet (Pirfenidone): Summary of Product Characteristics. www.ema.europa.eu/documents/product-information/esbriet-epar-product-information_eu.pdf.
  • Hagihara K, Nishiya Y, Kurihara A, Kazui M, Farid NA, Ikeda T. 2008. Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine. Drug Metab Pharmacokinet. 23(6):412–420.
  • Hanley MJ, Cancalon P, Widmer WW, Greenblatt DJ. 2011. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol. 7(3):267–286.
  • Hickman D, Wang JP, Wang Y, Unadkat JD. 1998. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metab Dispos. 26(3):207–215.
  • Hu JQ, Shang DW, Xu XW, He XL, Ni XJ, Zhang M, Wang ZZ, Qiu C, Deng SH, Lu HY, et al. 2016. Effect of grapefruit juice and food on the pharmacokinetics of pirfenidone in healthy Chinese volunteers: a diet-drug interaction study. Xenobiotica. 46(6):516–521.
  • Khojasteh SC, Prabhu S, Kenny JR, Halladay JS, Lu AY. 2011. Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet. 36(1):1–16.
  • Kobayashi K, Chiba K, Yagi T, Shimada N, Taniguchi T, Horie T, Tani M, Yamamoto T, Ishizaki T, Kuroiwa Y. 1997. Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes. J Pharmacol Exp Ther. 280(2):927–933.
  • Kobayashi K, Nakajima M, Oshima K, Shimada N, Yokoi T, Chiba K. 1999. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes. Drug Metab Dispos. 27(8):860–865.
  • Nakajima M, Nakamura S, Tokudome S, Shimada N, Yamazaki H, Yokoi T. 1999. Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs. Drug Metab Dispos. 27(12):1381–1391.
  • Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, Yokoi T. 2000. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Br J Clin Pharmacol. 49(3):244–253.
  • Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Pirfenidone Clinical Study Group in Japan, et al. 2010. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 35(4):821–829.
  • Verma N, Kumar P, Mitra S, Taneja S, Dhooria S, Das A, Duseja A, Dhiman RK, Chawla Y. 2018. Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: case report and mini-review of the literature. Hepatol Commun. 2(2):142–147.
  • Walsky RL, Obach RS. 2004. Validated assays for human cytochrome P450 activities. Drug Metab Dispos. 32(6):647–660.
  • Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T. 1994. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol Pharmacol. 46(3):568–577.
  • Yamazaki H, Tanaka M, Shimada T. 1999. Highly sensitive high-performance liquid chromatographic assay for coumarin 7-hydroxylation and 7-ethoxycoumarin O-deethylation by human liver cytochrome P450 enzymes. J Chromatogr B Biomed Sci Appl. 721(1):13–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.